Toll-like receptor (TLR) 2 recognizes and responds to threats early in bacterial infections and can influence the downstream immune response to the host's benefit or detriment. Therapeutic modulation of TLR2 signaling represents an underutilized opportunity to moderate the immune response to infection to promote an improved outcome for the host.
Keywords: TLR2; bacterial infection; immunotherapy; innate immunity.
Copyright © 2020 Elsevier Ltd. All rights reserved.